279 related articles for article (PubMed ID: 28293697)
1. Critical role of HMGA proteins in cancer cell chemoresistance.
D'Angelo D; Mussnich P; Arra C; Battista S; Fusco A
J Mol Med (Berl); 2017 Apr; 95(4):353-360. PubMed ID: 28293697
[TBL] [Abstract][Full Text] [Related]
2. The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin.
D'Angelo D; Borbone E; Palmieri D; Uboldi S; Esposito F; Frapolli R; Pacelli R; D'Incalci M; Fusco A
Eur J Cancer; 2013 Mar; 49(5):1142-51. PubMed ID: 23149213
[TBL] [Abstract][Full Text] [Related]
3. High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs.
D'Angelo D; Mussnich P; Rosa R; Bianco R; Tortora G; Fusco A
BMC Cancer; 2014 Nov; 14():851. PubMed ID: 25409711
[TBL] [Abstract][Full Text] [Related]
4. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
5. HMGA and cancer.
Fedele M; Fusco A
Biochim Biophys Acta; 2010; 1799(1-2):48-54. PubMed ID: 20123067
[TBL] [Abstract][Full Text] [Related]
6. Interplay between HMGA and TP53 in cell cycle control along tumor progression.
Meireles Da Costa N; Palumbo A; De Martino M; Fusco A; Ribeiro Pinto LF; Nasciutti LE
Cell Mol Life Sci; 2021 Feb; 78(3):817-831. PubMed ID: 32920697
[TBL] [Abstract][Full Text] [Related]
7. High Mobility Group A (HMGA): Chromatin Nodes Controlled by a Knotty miRNA Network.
Sgarra R; Pegoraro S; D'Angelo D; Ros G; Zanin R; Sgubin M; Petrosino S; Battista S; Manfioletti G
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979076
[TBL] [Abstract][Full Text] [Related]
8. High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression.
Sgarra R; Pegoraro S; Ros G; Penzo C; Chiefari E; Foti D; Brunetti A; Manfioletti G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):216-229. PubMed ID: 29518471
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
[TBL] [Abstract][Full Text] [Related]
10. Roles of HMGA proteins in cancer.
Fusco A; Fedele M
Nat Rev Cancer; 2007 Dec; 7(12):899-910. PubMed ID: 18004397
[TBL] [Abstract][Full Text] [Related]
11. [HMGA proteins and their genes as a potential neoplastic biomarkers].
Balcerczak E; Balcerczak M; Mirowski M
Postepy Biochem; 2005; 51(3):261-9. PubMed ID: 16381170
[TBL] [Abstract][Full Text] [Related]
12. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
[TBL] [Abstract][Full Text] [Related]
13. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
[TBL] [Abstract][Full Text] [Related]
14. HMGA proteins as therapeutic drug targets.
Reeves R; Beckerbauer LM
Prog Cell Cycle Res; 2003; 5():279-86. PubMed ID: 14593722
[TBL] [Abstract][Full Text] [Related]
15. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression.
Li J; Chen Y; Zhao J; Kong F; Zhang Y
Cancer Lett; 2011 May; 304(1):52-9. PubMed ID: 21354697
[TBL] [Abstract][Full Text] [Related]
16. Autophagy-mediating microRNAs in cancer chemoresistance.
Jing Y; Liang W; Liu J; Zhang L; Wei J; Yang J; Zhang Y; Huang Z
Cell Biol Toxicol; 2020 Dec; 36(6):517-536. PubMed ID: 32875398
[TBL] [Abstract][Full Text] [Related]
17. HMGA and Cancer: A Review on Patent Literatures.
De Martino M; Fusco A; Esposito F
Recent Pat Anticancer Drug Discov; 2019; 14(3):258-267. PubMed ID: 31538905
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-β signaling.
Zu X; Zhong J; Tan J; Tan L; Yang D; Zhang Q; Ding W; Liu W; Wen G; Liu J; Cao R; Jiang Y
Int J Mol Med; 2015 Mar; 35(3):693-701. PubMed ID: 25572132
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA Regulation of Energy Metabolism to Induce Chemoresistance in Cancers.
Ye J; Zou M; Li P; Liu H
Technol Cancer Res Treat; 2018 Jan; 17():1533033818805997. PubMed ID: 30444190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]